Benitec Biopharma Limited

Press Releases

2012-December-20	CRO Appointed for Hepatitis C Trial (in PDF)
2012-December-4	Cross Licenses with uniQure for Huntington's and Hep B (in PDF)
2012-December-3	Significant Gene Silencing Demonstrated in Benitec's Muscular Dystrophy Program (in PDF)
2012-November-20	Initiating Research Coverage (in PDF)
2012-November-16	Chairmans Address AGM 2012 (in PDF)
2012-November-13	Lung Cancer Program Gene Silencing (in PDF)
2012-October-30	Tacere Acquisition Completed (in PDF)
2012-October-22	Hepatitis C Patent Allowed in China (in PDF)
2012-October-11	Tacere Acquisition in Phase I/II Hepatitis C Program (in PDF)
2012-October-8	Hepatitis C Patent Granted in China (in PDF)
2012-October-3	Gene Therapy to Control Intractable Pain in Cancer Patients: A New Paradigm? - A Presentation at 6th Annual Pain Therapeutics Summit (in PDF)
2012-October-2	Pain Summit & Investor Conference (in PDF)
2012-September-25	Pathways to Revenue (in PDF)
2012-August-29	Preliminary Final Report (in PDF)
2012-August-13	Stanford University Research Agreement (in PDF)
2012-July-30	Efficacy in Transplant Rejection (in PDF)
2012-July-23	Positive European Regulator Decision (in PDF)
2012-July-18	Alnylam Positive Clinical Results (in PDF)
2012-July-10	Genable License Agreement (in PDF)
2012-June-28	Hep C Scientific Paper (in PDF)
2012-June-25	Withdrawal of Patent Revocation (in PDF)
2012-June-19	Therapeutic Program Update (in PDF)
2012-June-18	Executive Appointment (in PDF)
2012-May-31	New CSIRO Patents (in PDF)
2012-March-5	Calimmune License Deal (in PDF)
2012-February-29	Interim Report for the Half Year Ended December 31, 2011 (in PDF)
2012-February-7	Pre-Clinical Stem Cell Therapy Collaboration (in PDF)
2012-January-10	Cancer Vaccine Clinical Study Results (in PDF)
2012-January-9	Hepatitis C Pre Clinical Results (in PDF)
2015	2015 Press Releases
2014	2014 Press Releases
2013	2013 Press Releases
2011	2011 Press Releases